Offering products and solutions for all aspects of your oil and gas asset management workflow. More
Offering economic and financial analysis, forecasting, and market intelligence for 204 countries... More
Intelligence, consultancy and advertising solutions to the defense, national security and... More
IHS provides technical standards, codes and specifications plus the tools to manage critical data. More
Helping organizations drive innovation to achieve ESM goals with our software… More
Generating accurate price estimates, forecasts and analysis to help purchasing managers... More
Helping your business create a complete and profitable supply chain More
Every year IHS holds events across the world featuring valuable information from recognized experts. More
IHS regularly presents broad-audience, open-access webinars on current industry subjects. More
IHS takes pride in putting customers first and making sure that we keep you informed and updated More
Find the IHS news releases, media experts, corporate profile and more... More
The IHS experts combine specialized experience, expertise and vast professionalism to ensure that the company consistently meets all goals and objectives and maintains the core values and stringent ethics that have brought success in the past.
, Senior Healthcare Analyst, IHS
Floriane Reinaud, principal analyst at IHS Healthcare Practice, is responsible for a global pharmaceutical pricing database and has in-depth knowledge and experience in P&R policies, market access strategies and specialist topics, including orphan drugs and generics and biosimilars.
Floriane Reinaud joined Global Insight France in 2007 and has over 10 years of experience in the healthcare sector. She works as a Principal Analyst for the Healthcare and Pharma Division. Responsible for an international drug database with pricing and reimbursement in 40 countries, Floriane also publishes monthly bulletins providing valuable top-level analysis on the key drivers behind major price changes. Floriane also regularly contributes to consultancy projects. In her role, she has developed extensive and in-depth knowledge and experience of P&R policies, market access strategies and specialist topics such as risk-sharing agreements and orphan drugs, as well as price trends for generics and biosimilars. Floriane studied biology and holds an MS in Biochemistry as well as an MS in Healthcare Marketing. She coauthored a peer-reviewed article that was published in The Journal of Biological Biochemistry. Floriane is fluent in French and English.
|May 11, 2011||Pharmaceutical Launch Strategies: Pricing and Launch Sequence Optimization||Virtual_|
|November 15, 2012||European Turmoil 2012: A Review of Drug Prices and Market Access Across Europe||Virtual|
To change the font size, press Ctrl and (- or +)
To change the font size, Ctrl + (- or +)
If that didn’t work, try the following: